Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma
- PMID: 18813815
Relation between serum levels of cell-free DNA and inflammation status in hepatitis C virus-related hepatocellular carcinoma
Abstract
Our study revealed that the level of circulating cell-free DNA (cfDNA) is increased in the serum of patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). To gain insight into the mechanism underlying this phenomenon, we examined the association between cfDNA levels and various clinicopathological factors in 96 patients with HCV-related HCC and 99 non-HCC patients with HCV. Using pooled DNA microarray data, we profiled the expression patterns of inflammatory cytokine genes in 14 primary tumors from the group of HCC patients. We found that there were positive associations between the cfDNA level, aspartate aminotransferase levels and the number of leukocytes and neutrophils in patients with HCV-related HCC but not in non-HCC patients with HCV. The serum cfDNA level was not associated with other clinicopathological factors in HCC or non-HCC patients. A cluster analysis based on the inflammatory cytokine gene data revealed that HCCs with a high serum cfDNA level had increased levels of several inflammatory cytokine genes, suggesting that the serum cfDNA level is associated with the inflammatory status in primary tumors in HCV-related HCC.
Similar articles
-
Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma.Anticancer Res. 2006 Nov-Dec;26(6C):4713-9. Anticancer Res. 2006. PMID: 17214331
-
Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis.Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):164-9. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15668491
-
IL-18 and interferon-gamma in HCV-related hepatocellular carcinoma: a model of interplay between immune status and cancer.J Biol Regul Homeost Agents. 2009 Oct-Dec;23(4):251-8. J Biol Regul Homeost Agents. 2009. PMID: 20003764
-
The role of cytokines in hepatocellular carcinoma.J Leukoc Biol. 2006 Dec;80(6):1197-213. doi: 10.1189/jlb.0506297. Epub 2006 Aug 31. J Leukoc Biol. 2006. PMID: 16946019 Review.
-
Hepatitis C virus infection and hepatocellular carcinoma.Clin Liver Dis. 2008 Aug;12(3):661-74, x. doi: 10.1016/j.cld.2008.03.007. Clin Liver Dis. 2008. PMID: 18625433 Review.
Cited by
-
Cell-free DNA testing: future applications in gastroenterology and hepatology.Therap Adv Gastroenterol. 2019 Apr 15;12:1756284819841896. doi: 10.1177/1756284819841896. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31019553 Free PMC article. Review.
-
Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases.Int J Mol Sci. 2020 May 25;21(10):3732. doi: 10.3390/ijms21103732. Int J Mol Sci. 2020. PMID: 32466319 Free PMC article. Review.
-
Circulating tumor DNA in hepatocellular carcinoma: trends and challenges.Cell Biosci. 2016 May 11;6:32. doi: 10.1186/s13578-016-0100-z. eCollection 2016. Cell Biosci. 2016. PMID: 27182434 Free PMC article. Review.
-
Assessment of cell free mitochondrial DNA as a biomarker of disease severity in different viral infections.Pak J Med Sci. 2020 Jul-Aug;36(5):860-866. doi: 10.12669/pjms.36.5.2476. Pak J Med Sci. 2020. PMID: 32704253 Free PMC article.
-
Liquid Biopsy and its Potential for Management of Hepatocellular Carcinoma.J Gastrointest Cancer. 2016 Jun;47(2):157-67. doi: 10.1007/s12029-016-9801-0. J Gastrointest Cancer. 2016. PMID: 26969471 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical